About this Event
In today’s challenging fundraising climate, identifying the right investors and securing venture capital is more crucial than ever for biotech startups to remain competitive in the life sciences industry. Our panel of experts will provide valuable insights into the current market for dilutive capital investment types, emerging therapeutic areas, and what investors seek in startup companies.
We invite you to join us on May 31st 3pm-5pm to gain an understanding of the current state of dilutive capital investments and meet new and established faces in our region’s venture capital scene.
Moderator:
Michele Washko, President & CEO, Life Sciences Greenhouse Investments
Panelists:
Lorenzo Pellegrini, PhD, Managing Partner, Hatch Biofund
Frederick "Rick" Jones, MD, Partner, BioAdvance
Kathie Jordan, PhD, Managing Director, Healthcare Investment Group, Ben Franklin Technology Partners of Southeastern Pennsylvania
Sponsored by: CBRE, MVM Associates, Armstrong Teasdale, Meniscus Limited
Event Venue & Nearby Stays
The Wistar Institute, 3601 Spruce Street, Philadelphia, United States
USD 0.00